| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $453.2M | — | +2.8% |
| Cost of Revenue | $329.7M | — | +4.4% |
| Gross Profit | $123.5M | — | -1.3% |
| R&D Expense | $13.2M | — | +3.9% |
| SG&A Expense | $78.5M | — | +13.3% |
| Operating Income | $36.5M | — | -14.1% |
| Pre-tax Income | $39.9M | — | -10.1% |
| Income Tax | $9.1M | — | -21.6% |
| Net Income | $30.4M | — | -7.3% |
| EPS (Basic) | $1.23 | — | -6.1% |
| EPS (Diluted) | $1.22 | — | -6.9% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $289.1M | -1.2% | -3.6% |
| Accounts Receivable | $354.2M | +3.5% | +3.1% |
| Inventory | $321.5M | -2.4% | +1.9% |
| Current Assets | $999.1M | -0.5% | +2.3% |
| Total Assets | $1.82B | -0.7% | +2.5% |
| Current Liabilities | $334.8M | -7.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $17.6M | — | -37.8% |
| Capital Expenditures | $8.9M | — | +6.0% |
| Investing Cash Flow | -$13.7M | — | +11.6% |
| Financing Cash Flow | -$6.6M | — | -73.7% |
| Free Cash Flow | $8.7M | — | -56.3% |
| -6.4% |
| Total Liabilities | $467.6M | -6.4% | -8.1% |
| Stockholders' Equity | $1.34B | +1.4% | +6.7% |